Mechanisms of In-Vivo Remodeling in Tissue Engineered Heart Valves
组织工程心脏瓣膜体内重塑机制
基本信息
- 批准号:8465014
- 负责人:
- 金额:$ 77.42万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-07-05 至 2014-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Using autologous cells and biodegradable polymers, tissue engineered pulmonary valves (TEPV) have been fabricated and have functioned in the pulmonary circulation of growing lambs for up to 20 weeks, with tissue evolving into a differentiated layered structure resembling that of native valve. More recent studies have demonstrated that use of bone marrow mesenchymal stem cells (BMSC) and PGA/PLLA scaffolds produce functioning implants for up to 8 months in growing lambs which also demonstrated in-vivo structural evolution. These studies have demonstrated the feasibility of engineering pulmonary valve (PV) leaflets and segments of main pulmonary artery (PA) in-vitro. Both structures have functioned well without thrombosis. Moreover, both the gross and microscopic characteristics of the TEPV structures began to approximate those of normal tissues, strongly suggesting that cell phenotypes evolved in a directed fashion to remodel the valvular and vascular tissue. However, while these intriguing studies have yielded insight into TEPV development, our efforts thus far have been largely empirical. There remain significant bioengineering challenges in determining parameters that lead to optimal ECM development and strength. For example, despite the in-vivo evolution of TEPV valve tissue into a tri-layered structure that resembles native valve tissue, we have only very limited information on the extent to which TEPV truly duplicates native PV biomechanical function, nor the mechanisms that regulate the in-vivo remodeling process. The goal of the current research program is to thus quantify and simulate tissue remodeling events that occur post- implantation, and to understand the factors that influence the remodeling rate and the quality and architecture of the ultimate tissue. Specifically, we hypothesize that TEPV implant remodeling is primarily mediated by the level of in-vivo mechanical stimuli to the interstitial cells and developing ECM. Mechanical stimuli will affect the rate of scaffold degradation and the degree of post-implant cellular ingrowth. Relevance to public health includes the develop of valved pulmonary conduits for the pediatric population that can grow with the patient, minimizing the need for continued re-operations to bring the patient to adulthood.
描述(由申请人提供):使用自体细胞和生物可降解聚合物,制造了组织工程肺动脉瓣(TEPV),并在生长羔羊的肺循环中发挥作用长达20周,组织演变成类似于天然瓣膜的分化分层结构。最近的研究表明,使用骨髓间充质干细胞(BMSC)和PGA/PLLA支架在生长中的羔羊中产生长达8个月的功能植入物,这也证明了体内结构进化。这些研究已经证明了体外工程化肺动脉瓣(PV)小叶和主肺动脉(PA)段的可行性。两种结构功能良好,无血栓形成。此外,TEPV结构的总体和微观特征开始接近正常组织,强烈表明细胞表型以定向方式进化以重塑瓣膜和血管组织。然而,尽管这些有趣的研究已经深入了解了TEPV的发展,但我们迄今为止的努力主要是经验性的。在确定导致最佳ECM发展和强度的参数方面仍然存在重大的生物工程挑战。例如,尽管TEPV瓣膜组织在体内演变成类似于天然瓣膜组织的三层结构,但我们只有非常有限的关于TEPV真正复制天然PV生物力学功能的程度的信息,也没有调节体内重塑过程的机制。因此,当前研究计划的目标是量化和模拟植入后发生的组织重塑事件,并了解影响重塑速率以及最终组织的质量和结构的因素。具体而言,我们假设TEPV植入物重塑主要是由间质细胞和发育中的ECM的体内机械刺激水平介导的。机械刺激将影响支架降解的速率和植入后细胞向内生长的程度。与公共卫生的相关性包括为儿科人群开发带瓣肺管道,该管道可以与患者一起生长,最大限度地减少继续再次手术以使患者成年的需要。
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Pulmonary artery conduit in vivo dimensional requirements in a growing ovine model: comparisons with the ascending aorta.
生长羊模型中的肺动脉导管体内尺寸要求:与升主动脉的比较。
- DOI:
- 发表时间:2013
- 期刊:
- 影响因子:0
- 作者:Gottlieb,Danielle;Fata,Bahar;Powell,AndrewJ;Cois,CAaron;Annese,David;Tandon,Kunal;Stetten,George;MayerJr,JohnE;Sacks,MichaelS
- 通讯作者:Sacks,MichaelS
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael S Sacks其他文献
Michael S Sacks的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael S Sacks', 18)}}的其他基金
GAGs: Function and Fixation in Bioprosthetic Heart Valves
GAG:生物人工心脏瓣膜的功能和固定
- 批准号:
7822283 - 财政年份:2009
- 资助金额:
$ 77.42万 - 项目类别:
GAGs: Function and Fixation in Bioprosthetic Heart Valves
GAG:生物人工心脏瓣膜的功能和固定
- 批准号:
7884386 - 财政年份:2008
- 资助金额:
$ 77.42万 - 项目类别:
GAGs: Function and Fixation in Bioprosthetic Heart Valves
GAG:生物人工心脏瓣膜的功能和固定
- 批准号:
7683027 - 财政年份:2008
- 资助金额:
$ 77.42万 - 项目类别:
GAGs: Function and Fixation in Bioprosthetic Heart Valves
GAG:生物人工心脏瓣膜的功能和固定
- 批准号:
8099573 - 财政年份:2008
- 资助金额:
$ 77.42万 - 项目类别:
GAGs: Function and Fixation in Bioprosthetic Heart Valves
GAG:生物人工心脏瓣膜的功能和固定
- 批准号:
7532124 - 财政年份:2008
- 资助金额:
$ 77.42万 - 项目类别:
Mechanisms of In-Vivo Remodeling in Tissue Engineered Heart Valves
组织工程心脏瓣膜体内重塑机制
- 批准号:
7673989 - 财政年份:2007
- 资助金额:
$ 77.42万 - 项目类别:
Mechanisms of In-Vivo Remodeling in Tissue Engineered Heart Valves
组织工程心脏瓣膜体内重塑机制
- 批准号:
7303310 - 财政年份:2007
- 资助金额:
$ 77.42万 - 项目类别:
Mechanisms of In-Vivo Remodeling in Tissue Engineered Heart Valves
组织工程心脏瓣膜体内重塑机制
- 批准号:
7460939 - 财政年份:2007
- 资助金额:
$ 77.42万 - 项目类别:
相似国自然基金
基于ex vivo模型联合多组学手段绘制胃癌曲妥珠单抗继发耐药机制并探索克服耐药策略
- 批准号:
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
神经干细胞治疗帕金森病大鼠模型:在体(in vivo)实时记录纹状体多巴胺分泌
- 批准号:81571235
- 批准年份:2015
- 资助金额:57.0 万元
- 项目类别:面上项目
基于in vivo动力学分析的波动环境下黑曲霉产酶得率调控机制研究
- 批准号:21506052
- 批准年份:2015
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
siRNA基因沉默与诱导双向基因治疗关节炎的软骨、滑膜生物学响应及ex vivo系统转基因在体示踪研究
- 批准号:81171774
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
Quantifying the relationship between intracortical remodeling, microdamage, and bone quality in a novel in vivo loading model
在新型体内负荷模型中量化皮质内重塑、微损伤和骨质量之间的关系
- 批准号:
478357 - 财政年份:2023
- 资助金额:
$ 77.42万 - 项目类别:
Operating Grants
Mechanisms of sperm chromatin remodeling in vivo and in vitro
精子染色质体内外重塑机制
- 批准号:
10753662 - 财政年份:2023
- 资助金额:
$ 77.42万 - 项目类别:
Swi/Snf chromatin remodeling activity is required for islet cell development in vivo
Swi/Snf 染色质重塑活性是胰岛细胞体内发育所必需的
- 批准号:
10314133 - 财政年份:2021
- 资助金额:
$ 77.42万 - 项目类别:
The Pdx1-recruited Swi/Snf chromatin remodeling complex regulates endocrine cell expansion and differentiation in vivo
Pdx1 招募的 Swi/Snf 染色质重塑复合物调节体内内分泌细胞的扩增和分化
- 批准号:
10321296 - 财政年份:2021
- 资助金额:
$ 77.42万 - 项目类别:
In vivo Assessment of Chemotherapy Remodeling of the Bladder Cancer Immune Microenvironment
膀胱癌免疫微环境化疗重塑的体内评估
- 批准号:
10819107 - 财政年份:2020
- 资助金额:
$ 77.42万 - 项目类别:
In vivo vascular remodeling: Molecular mechanisms of blood flow sensing and response by vascular endothelial cells
体内血管重塑:血管内皮细胞血流感知和响应的分子机制
- 批准号:
19K16140 - 财政年份:2019
- 资助金额:
$ 77.42万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Myelin remodeling in vivo: A longitudinal study of targeted myelination and neuronal control of sparse myelination in mouse cortex
体内髓鞘重塑:小鼠皮质中靶向髓鞘形成和稀疏髓鞘形成的神经元控制的纵向研究
- 批准号:
426715780 - 财政年份:2019
- 资助金额:
$ 77.42万 - 项目类别:
Research Grants
The effects of amyloid beta on pericyte remodeling and brain capillary function in vivo
β淀粉样蛋白对体内周细胞重塑和脑毛细血管功能的影响
- 批准号:
9898221 - 财政年份:2019
- 资助金额:
$ 77.42万 - 项目类别:
Direct tracking of cortical bone remodeling in vivo in a Rabbit Model
兔模型体内皮质骨重塑的直接跟踪
- 批准号:
511348-2017 - 财政年份:2017
- 资助金额:
$ 77.42万 - 项目类别:
University Undergraduate Student Research Awards
The effect of local inter-nucleosomal interactions and chromatin remodeling on in vivo chromatin fiber folding
局部核小体间相互作用和染色质重塑对体内染色质纤维折叠的影响
- 批准号:
9325353 - 财政年份:2017
- 资助金额:
$ 77.42万 - 项目类别: